Home      Tickers | SPY | NQ100 | DOW | Global | ETFs | Sector ETFs | 3x ETFs | ETF Movers | Stock Movers | Trading Alerts
     ^  TYME:  Intraday  Hourly  Forecast  Similar  Waves  GapOpen  Research  Timing  Gains  Losses  Strategies  Practice
     Fri. Jan. 26, 2018

Trading Signals: TYME Stock Price Prediction and Forecast (Tue. Aug. 15, 2017 - Fri. Jan. 26, 2018)

(Tyme Technologies)

TYME latest price $5.0100 (-2.91%) ($4.9100 - $5.1000) on Fri. Jan. 26, 2018.


Trend Analysis and Forecast
 
Average Daily Percentage Swing  7.54% (three month average)
RSI   28
Latest Price   $5.0100(-2.91%)
Stocks Behave Similarly  Similar Stock List
Daily Trend  TYME declines -4% a day on average for past five trading days.
Weekly Trend  TYME declines -11% a week on average for past two weeks.
Market Behavior  Broad based rally for large cap. Growth stock rally for small cap.
Correlated ETFs  Broad market will support TYME advance at 0% a week (0% probability)
  REMX(5%)    VWO(-59%)    EWG(-40%)    EWY(35%)    EWP(33%)  
Factors Impacting TYME price  TYME will decline at least -3.77% in a week (0% probabilities).
  EWP(33%)    EWY(35%)    EWG(-40%)    VWO(-59%)    REMX(5%)  
 
 
Relative Volatility  
 
Market Trend Strength  -3.77% (StdDev 7.54%)
Hourly BBV   0 ()
Intraday Trend   -1.8%
  
 

  


1 - 5 Day Possible Target  $-12.98(-359.08%)
Resistance Level  $6.26
5 Day Moving Average  $5.34(-6.18%)
10 Day Moving Average  $5.9(-15.08%)
20 Day Moving Average  $6.26(-19.97%)
To recent high  -31.4%
To recent low  0%
Market Cap  $854m
 
 
 
Tyme Technologies, Inc., is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Company's therapeutic approach is designed to take advantage of a cancer cell's innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body's natural immune system. With the development of TYME-18 and TYME-19, the Company believes that it is also emerging as a leader in the development of bile acids as potential therapies for cancer and COVID-19.

$. TYME price fluctuates within 10.38% (three month std-dev: 7.54%) daily (68% of days).

Sample size 13   Average positive next day return: 6.03%(77%)   Average negative next day return: -0.2%(23%)
Sample size 13   Average positive next three day return: 8.28%(69%)   Average negative next three day return: -4.91%(31%)
Sample size 13   Average positive next weekly return: 7.41%(77%)   Average negative next weekly return: -3.03%(23%)

Analysis   News   Options   Weekly Chart   Daily Chart   2 Month Daily Chart   

  >  20180226

iDateema100ema20ema10 ema5 Slow Hourly
Trend
Fast Hourly
Trend
ClosePatternTradePSMA5
BBV
 WTF lsma10
Trend
ema5
Trend
ema10
Trend
Volume
millions
Quarterly
Strength
100
Daily
Trend
Daily
Trend
Force
Daily
StdDev
Hourly
BBV
BBVRSIVIXCD
1Jan_26_20186.256.265.95.34 5.23 5.095.01(-2.91%)DTOpenShort-75-0.5   -32   -250   -12   -92   0.05    62%-1.42-57.87.54%0-1.928136.8
2Jan_25_20186.346.356.15.56 5.48 5.155.16(-3.01%)DTOpenShort-75-0.7   -29   -460   -12   -78   0.09    62%-1.25-45.57.55%0-2.129137.4
3Jan_24_20186.426.436.265.76 5.77 5.365.32(3.3%)DPOpenShort-75-0.9   -32   -490   -19   -69   0.35    62%-0.77-23.37.55%0-2.235-1.4
4Jan_23_20186.476.56.416.09 6.12 5.815.15(-15.3%)DTOpenShort-75-2.2   -25   -340   -18   -46   0.33    62%-0.4627.37.54%0-3.1350.1
5Jan_22_20186.56.626.546.43 6.4 6.186.08(-0.16%)DTOpenShort-75-1.2   -12   -250   -8   -22   0.18    74%0.151387.26%0-1.8490.9
 
6Jan_19_20186.496.666.636.55 6.6 6.436.09(-0.98%)DTOpenShort-75-1.6   -7   -160   -8   -5   0.65    74%-0.15233.87.32%0-2531